Skip to main content

Table 3 Differences of marginal means of myoglobin clearances in CVVHD-HCO and CVVHD-CS (ml/min)a

From: Kidney REPLACEment therapies in patients with acute kidney injury and RHABDOmyolysis (ReplaceRhabdo): a pilot trial

Time after starting KRT

n

CVVHD-HCO n = 5

CI

p

1 h

15

3.39

-8.67–15.45

0.545

6 h

15

-0.96

-5.46–3.54

0.644

12 h

14

17.42

6.99–27.84

0.004

24 h

13

-4.24

-22.51–14.04

0.617

Time after starting KRT

n

CVVHD-CS n = 5

CI

p

1 h

15

18.37

6.923- 29.80

0.005

6 h

15

4.24

-0.03- 8,51

0.051

12 h

14

12.42

2.53- 22.31

0.019

24 h

13

-12.57

-29.90- 4.76

0.137

  1. Data presented as marginal means and 95% confidence interval of marginal means
  2. CI 95% confidence interval, CS CytoSorb®, CVVH continuous veno-venous hemofiltration, CVVHD continuous veno-venous hemodialysis, HCO high cut-off, KRT kidney replacement therapy
  3. aThe clearance in reference group (CVVH) was set equal to zero